Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects (Q69517342)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2663901%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

review article

1 reference

title

Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2663901%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

author name string

B A Davis

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2663901%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

publication date

1 April 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2663901%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

volume

466

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2663901%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

page(s)

89-218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2663901%20AND%20SRC:MED&resulttype=core&format=json

Variations of urinary creatinine and its correlation to excretion of indole metabolites in mental patients

2 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Variations of Urinary Creatinine and its Correlation to Tryptamine Excretion in Schizophrenic Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

CSF creatinine in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The variability of creatinine excretion in normal subjects, mental patients and pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Indoleamine metabolism in affective disorders: Excretion of tryptamine, indoleacetic acid and 5-hydroxyindoleacetic acid in depressive states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of urinary 3-methoxy-4-hydroxymandelic acid in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

24-h catecholamine excretion: relationships with age and weight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Measurement of the two conjugates of 3-methoxy-4-hydroxyphenylglycol in urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Stability of creatinine, urea and uric acid in urine stored under various conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The significance of homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations in human lumbar cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Correlations between aminergic metabolites simultaneously obtained from human CSF and brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Decreased CSF concentrations of homovanillic acid and gamma-aminobutyric acid in Alzheimer's disease. Age- or disease-related modifications?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The content of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid of patients with acute schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma homovanillic acid concentration and the severity of schizophrenic illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Estimates of Dopamine and Serotonin Synthesis by the Awake Human Brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Schizophrenia: elevated cerebrospinal fluid norepinephrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Alteration of circadian rhythmicities of urinary 3-methoxy-4-hydroxyphenylglycol (MHPG) and vanilmandelic acid (VMA) in man during cold exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Conversion of MHPG to vanillylmandelic acid. Implications for the importance of urinary MHPG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The effect of lithium on urinary MHPG in unipolar and bipolar depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

3-Methoxy-4-Hydroxyphenethyleneglycol Production by Human Brain in Vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma MHPG in depression: effects of acute and chronic desipramine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Clinical studies on norepinephrine metabolism: how to interpret the numbers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Catecholamines and their major metabolites in plasma and cerebrospinal fluid of man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Depressive symptom patterns and urinary MHPG excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

3-Methoxy-4-hydroxyphenylglycol in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma free and conjugated MHPG in psychiatric patients. A pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Catecholamine metabolites in human plasma as indices of brain function: effects of debrisoquin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Decreased cerebrospinal fluid concentration of free phenylacetic acid in depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Phenylacetic acid in human body fluids: high correlation between plasma and cerebrospinal fluid concentration values

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The estimation of catecholamines in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Analytical differences between the determination of plasma catecholamines by liquid chromatography with electrochemical detection and by radioenzymatic assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

On the measurement of 5-hydroxyindoleacetic acid in cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Interference with the fluorometric assay for homovanillic acid caused by acid metabolites of catecholamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A comparison between fluorometric and mass fragmentographic determinations of homovanillic acid and 5-hydroxyindoleacetic acid in human cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Comparison of high-performance liquid chromatographic, gas chromatographic—mass spectrometric, and fluorometric methods for the determination of homovanillic acid and 5-hydroxyindoleacetic acid in human cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Correlations between a fluorimetric and mass fragmentographic method for the determination of 3-methoxy-4-hydroxyphenylacetic acid and two mass fragmentographic methods for the determination of 3-methoxy-4- hydroxyphenylethylene glycol in cerebrospi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Quantitation of biologically important primary amines as their isothiocyanate derivatives by gas chromatography using nitrogen detector and validation by selected ion monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Application of combined gas chromatography/mass spectrometry to neurotransmitter research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Quantitation of catecholamine metabolites by gas chromatography-mass spectrometry with selected ion monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Analysis of monoamines and their metabolites by high performance liquid chromatography with coulometric electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Chromatographic approaches to signal and selectivity enhancement for determination of biogenic amines by liquid chromatography with amperometric detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Analytical techniques for the determination of phenolic amine neurotransmitter conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Longitudinal urinary trace amine excretion in a human male

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Longitudinal urinary excretion of some "trace" acids in a human male

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Reliability of urinary monoamine and metabolite output measurements in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Excretion of MHPG in normal subjects: implications for biological classification of affective disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary excretion of O-methylated catecholamines, tyramine and phenyl-ethylamine by volunteers treated with tranylcypromine and CGP 11305 A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary phenylacetate and response to methylphenidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

3,4-Dimethoxyphenylethylamine excretion of normals and schizophrenics, behaviour during total fasting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

3-Methoxy-4-hydroxyphenethylene glycol in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effects of oral clonidine on plasma 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) in man: preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Indices of noradrenergic output in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effect of diet on urinary excretion of histamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary excretion of histamine in healthy human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary Excretion of Free and Conjugated Histamine in Healthy Individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Measurement of urinary histamine: development of methodology and normal values

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Modification of the enzymatic isotopic assay of histamine and its application to measurement of histamine in tissues, serum and urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Histamine levels in plasma, blood, and urine in severe asthma, and the effect of corticosteroid treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Blood and urine histamine levels in normal and pathological states as measured by a radiochemical assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Histamine and some of its metabolites in human body fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous determination of histamine and Nτ-methylhistamine in human urine and rat brain by high-performance liquid chromatography with fluorescence detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A fluorometric assay for beta-phenylethylamine in human urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A method for the estimation of 2-phenylethylamine in human urine by gas chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary phenylethylamine excretion: Gas chromatographic assay with electron-capture detection of the pentafluorobenzoyl derivative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Deficient production of tyramine and octopamine in cases of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Screening for amines of psychiatric interest in urine using gas chromatography with electron-capture detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Separation and quantitation of some urinary arylalkylamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Investigation of some biological trait markers in migraine: deuterated tyramine challenge test, monoamine oxidase, phenolsulfotransferase and plasma and urinary biogenic amine and acid metabolite levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Mass fragmentography of phenylethylamine, m- and p-tyramine and related amines in plasma, cerebrospinal fluid, urine, and brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Phenylethylamine in paranoid chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of beta-phenylethylamine as its isothiocyanate derivative in biological samples by gas chromatography mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary trace amine excretion and platelet monoamine oxidase activity in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

URINARY EXCRETION OF PHENETHYLAMINE AND TYRAMINE IN NORMAL SUBJECTS AND HETEROZYGOUS CARRIERS OF PHENYLKETONURIA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Conjugation Defect in Tyramine-sensitive Migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Dietary Migraine and Tyramine Metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The estimation of true urinary tyramine in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Aromatic Amines and Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Alterations in the pattern of amine excretion in man produced by a monoamine oxidase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Pink Spot, p-Tyramine and Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary excretion of free tyramine and of norepinephrine and its metabolites in unipolar depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Separation and characterization of urinary indoles resembling 5-hydroxytryptamine and tryptamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary excretion of serotonin (5-hydroxytryptamine) and related indoles in normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Thyroid-imipramine clinical and chemical interaction: Evidence for a receptor deficit in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

CNS monoamine metabolism in bipolar affective disorder. Evaluation using a peripheral decarboxylase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

False neurotransmitters and hepatic failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A method for semiautomatic differential analysis of urinary catecholamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Automated specific fluorimetric methods for epinephrine and norepinephrine assay in a single biolgical extract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Factors Influencing the Urinary Excretion of Free Catecholamines in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous quantitation of catecholamines and metabolites in urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Role of biogenic amines in certain pathological conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effect of smoking on the urinary output of epinephrine and norepinephrine in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Catecholamine excretion in men exposed to cold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

New automated fluorometric methods for estimation of small amounts of adrenaline and noradrenaline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Isolation of catecholamines in biological fluids by boric acid gel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Rapid procedure for chromatographic isolation of DOPA, DOPAC, epinephrine, norepinephrine and dopamine from a single urinary sample at endogenous levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Gas chromatographic measurement of urinary catecholamines by an electron capture detection procedure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary monoamine metabolites as indices of mental stress in healthy males and females

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Measurement of catecholamines in biological fluids by high-performance liquid chromatography: a comparison of fluorimetric with electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Assay of free and conjugated catecholamines by high-performance liquid chromatography with electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Modified sample preparation for high-performance liquid chromatographic--electrochemical assay of urinary catecholamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

High urinary norepinephrine excretion in major depressive disorders: effects of a new type of MAO inhibitor (Moclobemide, RO 11-1163)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary norepinephrine excretion in panic and phobic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

High-performance liquid chromatographic determination of urinary catecholamines by pre-column solid-phase dansylation on alumina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Fluorimetric determination of urinary adrenaline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Acid Metabolites from Monoamines in Cerebrospinal Fluid of Chronic Schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Dopamine Excretion in Affective States and following Li2CO3 Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Free and Conjugated Plasma and Urinary Dopamine in Human Hypertension*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma and urinary dopamine: studies during fasting and exercise and in tetraplegic man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Method for analysis of dopamine sulfate isomers by high performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Influencing the human indoleamine metabolism by means of a chlorinated amphetamine derivative with antidepressive action (p-Chloro-N-Methylamphetamine)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of O-conjugates of 5-hydroxytryptamine in human urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Quantitative Determination of Metadrenaline and Normetadrenaline in Normal Human Urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A simplified method for the differential estimation of metanephrine and normetanephrine in urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Diagnostic subgroups of affective disorders and their urinary excretion of catecholamine metabolities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

An improved method for the differential assay of 3-omethylated catecholamines in human urine using ion-pair extraction and gas chromatography electron capture detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effects of Caffeine on Plasma Renin Activity, Catecholamines and Blood Pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A selective and sensitive assay for urinary metanephrine and normetanephrine using gas chromatography mass spectrometry with selected ion monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary catecholamine metabolites distinguish different types of sympathetic neuronal dysfunction in patients with orthostatic hypotension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Analysis of urinary metanephrines by reversed-phase high-performance liquid chromatography and electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Quantitative fluorimetric determination of urinary 3-methoxytyramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

INVESTIGATION ON THE OCCURRENCE OF THE DOPAMINE METABOLITE 3,4-DIMETHOXYPHENYLETHYLAMINE IN THE URINE OF SCHIZOPHRENICS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Radioimmunological determination of 3,4-dimethoxyphenylethylamine in urine (author's transl)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Factors affecting the urinary excretion of endogenously formed dimethyltryptamine in normal human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Mass fragmentographic quantification of urinary N,N-dimethyltryptamine and bufotenine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A test of the transmethylation hypothesis in acute schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary melatonin rhythms during sleep deprivation in depressed patients and normals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Measurement of 6-hydroxymelatonin in human urine and its diurnal variations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Identification and quantification of 5-methoxyindole-3-acetic acid in human urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of catecholamine sulfoconjugate isomers in normal human urine by use of high-performance liquid chromatography with a photochemical detector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Sample preparation procedure for determination of dopamine sulfate isomers in human urine by high-performance liquid chromatography with dual-electrode electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary monoamines and monoamine metabolites in subtypes of unipolar depressive disorder and normal controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of dopamine-3- and 4-O-sulphate in human plasma and urine by anion-exchange high-performance liquid chromatography with fluorimetric detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

High correlation of norepinephrine and its major metabolite excretion rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Measurement and normal range of free histamine in human blood plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Enzymatic isotopic assay for human plasma histamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Measurement of plasma histamine in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A new radioenzymatic assay for histamine using purified histamine N-methyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A sensitive and specific radiometric method for the measurement of plasma histamine in normal individuals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma histamine and catecholamines in stable asthmatic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Measurement of plasma histamine: description of an improved method and normal values

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of histamine in plasma by high-speed liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A direct and sensitive determination of histamine in acid-deproteinized biological samples by high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous determination of histamine and N tau-methylhistamine in human plasma and urine by gas chromatography--mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Measurement of plasma histamine by stable isotope dilution gas chromatography-mass spectrometry: methodology and normal values

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of N tau-methylhistamine in plasma and urine by isotope dilution mass fragmentography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effects of tranylcypromine stereoisomers on monamine oxidation in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma phenylethylamine and phenylalanine in chronic schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Octopamine plasma levels and hepatic encephalopathy: a re-appraisal of the problem.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The estimation of epinephrine and norepinephrine in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Fluorimetric determination of plasma catecholamines: Normal human epinephrine and norepinephrine levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A fluorometric assay for subnanogram concentrations of adrenaline and noradrenaline in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Blood levels of adrenergic amines during exercise.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Catecholamine concentrations in CSF and plasma of patients with cerebral infarction and haemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

AN IMPROVED METHOD FOR FLUORIMETRIC DETERMINATION OF SMALL AMOUNTS OF ADRENALINE AND NORADRENALINE IN PLASMA AND TISSUES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A sensitive and specific fluorimetric method for the determination of noradrenalin and adrenalin in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A sensitive double-isotope derivative assay for norepinephrine and epinephrine. Normal resting human plasma levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Measurement of Norepinephrine and Epinephrine in Small Volumes of Human Plasma by a Single Isotope Derivative Method: Response to the Upright Posture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Evaluation of transcendental meditation as a method of reducing stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Estimation of plasma catecholamines in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Increased plasma adrenaline concentrations in benign essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A simple specific radioenzymatic assay for the simultaneous measurement of picogram quantities of norepinephrine, epinephrine, and dopamine in plasma and tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma catecholamines and cardiovascular responses to cold and mental activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effect of Sodium Intake on Plasma Catecholamines in Normal Subjects*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma dopamine responses to standing and exercise in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A radioenzymatic microassay for simultaneous measurement of catecholamines and their deaminated metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Radioenzymatic assay of sulfate conjugates of catecholamines and DOPA in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma norepinephrine levels are influenced by sodium intake, glucocorticoid administration, and circadian changes in normal man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma free and sulfate conjugated catecholamine levels during acute physiological stimulation in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Glucuronide and sulfate catecholamine conjugates in rat and human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The effect of ascorbic acid on plasma sulfate conjugated catecholamines after eating bananas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Enzymatic deconjugation of catecholamines in human and rat plasma and red blood cell lysate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma levels of free and total catecholamines and two deaminated metabolites in man--rapid deconjugation by heat in acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Hemodynamic, ventilatory, and biochemical responses of panic patients and normal controls with sodium lactate infusion and spontaneous panic attacks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A sensitive radioenzymatic assay for norepinephrine in tissues and plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Assay of cathecholamines in human plasma: studies of a single isotope radioenzymatic procedure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma noradrenaline increases with age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Age-adjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma norepinephrine and dopamine-beta-hydroxylase activity in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A double isotope dilution method for differential determination of adrenaline and noradrenaline in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma norepinephrine and epinephrine in untreated diabetics, during fasting and after insulin administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Conjoint radioenzymatic measurement of catecholamines, their catechol metabolites and DOPA in biological samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of catecholamines by radioenzymatic assay using ion-pair liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Comparative analysis of indices of central dopaminergic functions in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma Dopamine β-Hydroxylase and Noradrenaline Amounts in Essential Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A sensitive radioenzymatic assay for adrenaline and noradrenaline in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma Levels of Norepinephrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma Catecholamines in Stress and Exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Sequential changes in plasma noradrenaline during bicycle exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of free and conjugated catecholamines and L-3,4-dihydroxyphenylalanine in plasma and urine: evidence for a catechol-O-methyltransferase inhibitor in uraemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Narcolepsy and idiopthic hypersomnia: biogenic amines and related compounds in CSF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of noradrenaline and adrenaline in plasma by a radioenzymatic assay using high pressure liquid chromatography for the separation of the radiochemical products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Gas-liquid chromatographic and mass fragmentographic determination of catecholamines in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A gas chromatography-mass spectrometry assay of human plasma catecholamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

An improved method for determination of plasma norepinephrine: isolation by boric acid gel and assay by selected ion monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A sensitive method for the determination of plasma catecholamines using liquid chromatography with electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A comparison of noradrenaline, HMPG and VMA in plasma as indicators of sympathetic nerve activity in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Dexamethasone increases plasma free dopamine in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous assay of 3,4-dihydroxyphenylethylene glycol and norepinephrine in human plasma by high-performance liquid chromatography with electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous assay of 3,4-dihydroxyphenylalanine, catecholamines and O-methylated metabolites in human plasma using high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma norepinephrine level in affective disorders. Relationship to melancholia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Exaggerated orthostatic responsivity of plasma norepinephrine in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous measurement of urinary and plasma norepinephrine, epinephrine, dopamine, dihydroxyphenylalanine, and dihydroxyphenylacetic acid by coupled-column high-performance liquid chromatography on C8 and C18 stationary phases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Psychotic and nonpsychotic depressions: I. Comparison of plasma catecholamines and cortisol measures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma norepinephrine responses to cold challenge in depressed patients and normal controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Assay of catecholamines and dihydroxyphenylethyleneglycol in human plasma and its application in orthostasis and mental stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Estimation of catecholamines in human plasma by ion-exchange chromatography coupled with fluorimetry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Method for the fluorimetric estimation of dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A sensitive assay for the determination of dopamine in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Circadian rhythm in circulating concentration of dihydroxyphenylacetic acid in normal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of plasma catecholamines and free 3,4-dihydroxyphenylacetic acid in continuously collected human plasma by high performance liquid chromatography with electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

An improved specific and sensitive radioenzymatic method for determination of serotonin concentrations in biological fluids (radioenzymatic serotonin method)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Radioenzymatic microassay for picogram quantities of serotonin or acetylserotonin in biological fluids and tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Serotonin in body fluids: characterization of human plasmatic and cerebrospinal fluid pools by means of a new HPLC method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Decreased plasma serotonin in melancholic patients: A study with clomipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of serotonin in whole blood, platelet-rich plasma, platelet-poor plasma and plasma ultrafiltrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of plasma serotonin by high-performance liquid chromatography with pre-column sample enrichment and fluorimetric detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Indoleamine compartmentation in human blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A radioenzymatic assay for plasma normetanephrine in man and patients with pheochromocytoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Gas chromatographic-mass spectrometric isotope dilution assay for N,N-dimethyltryptamine in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Gas chromatographic-mass spectrometric isotope dilution determination of N,N-dimethyltryptamine concentrations in normals and psychiatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Analysis of melatonin in human plasma by gas chromatography negative chemical ionization mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Synchronous nyctohemeral rhythms in human blood melatonin and in human post-mortem pineal enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Entrainment of rhythmic melatonin secretion in man to a 12-hour phase shift in the light/dark cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The influence of acute and subchronic administration of various antidepressants on early morning melatonin plasma levels in healthy subjects: increases following fluvoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A gas chromatography-mass spectrometry method for the quantitative analysis of melatonin in plasma and cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Oral load of tyrosine or L-dopa and plasma levels of free and sulfoconjugated catecholamines in healthy men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

CSF sulfoconjugated catecholamines in man: their relationship with plasma catecholamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Dopamine sulfate formation and phenol sulfotransferase activity in dog and human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of catecholamines in the plasma of patients with essential hypertension and of normal persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Identification and Determination of Tele‐Methylhistamine in Cerebrospinal Fluid by Gas Chromatography‐Mass Spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The effect of pimozide on CSF norepinephrine in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Noradrenergic Overactivity in Chronic Schizophrenia: Evidence Based on Cerebrospinal Fluid Noradrenaline and Cyclic Nucleotide Concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Dopamine and noradrenalin in the cerebrospinal fluid of schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Genetic factors in affective illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Liquid chromatographic assay for CSF catecholamines using electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Cerebrospinal fluid and plasma monoamines and their metabolites in euthymic bipolar patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of tyrosine, tryptophan and their metabolic derivatives by liquid chromatography-electrochemical detection: application to post mortem samples from patients with Parkinson's and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Catecholamine level in cerebrospinal fluid of epileptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Serotoninergic system in dementia of the Alzheimer type. Abnormal forms of 5-hydroxytryptophan and serotonin in cerebrospinal fluid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Liquid chromatographic assay for cerebrospinal fluid serotonin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Extractive acylation and mass spectrometric assay of 3-methoxytyramine, normetanephrine, and metanephrine in cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Radioimmunoassay of Melatonin: Human Serum and Cerebrospinal Fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Improved selective ion monitoring mass-spectrometric assay for the determination of n,n-dimethyltryptamine in human blood utilizing capillary column gas chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of conjugated dopamine in cerebrospinal fluid from humans and non-human primates with high performance liquid chromatography using electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of imidazole acetic acid and its conjugate(s) levels in urine, serum and tissues of rats: studies on changes in their levels under various conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous determination of imidazoleacetic acid and N tau- and N pi-methylimidazoleacetic acids in human urine by high-performance liquid chromatography with fluorescence detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Gas chromatographic analysis of histamine metabolites in urine. Quantitative determination of ring methylated imidazoleacetic acids in healthy man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Phenylacetic acid excretion in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Quantitative aspects of urinary indole-3-acetic acid and 5-hydroxyindole-3-acetic acid excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary neurotransmitter metabolites in drug-free chronic schizophrenic patients measured by gas chromatography selected positive ion monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Identification and quantitative determination of o- and m-hydroxymandelic acid in human urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Excretion of m-hydroxymandelic acid in human urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary excretion of the serotonin metabolite, 5-hydroxyindoleacetic acid, in various clinical conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

On the relationship of serotonin to schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Blood and urinary serotonin and 5-hydroxyindole acetic acid levels in schizophrenic patients and normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Tryptophan metabolism in affective psychoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Tryptophan loading and excretion of 5-hydroxyindoleacetic acid in normal and schizophrenic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

THE SIGNIFICANCE OF MONOAMINE OXIDASE INHIBITION AS AN ANTIDEPRESSIVE PRINCIPLE. I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of urinary 5-hydroxyndole-3-acetic acid by high-speed liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

High-performance liquid chromatographic determination of 5-hydroxyindole-3-acetic acid in urine using Sephadex G-10 for isolation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of 5-hydroxyindoleacetic acid in urine by high-performance liquid chromatography: a fully automated method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Fluorometric determination of homovanillic acid in cerebrospinal fluid, urine, and blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The quantitative estimation of urinary 3-methoxy-4-hydroxy phenylacetic acid (Homovanillic acid)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

On the occurrence of glusulase-hydrolyzable conjugates of 3,4-dihydroxy-phenylacetic and homovanillic acids in human urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous separation of acid metabolites of catecholamines: Application to urine and tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

An improved method for the estimation of homovanillic acid in human urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A simple chromatographic procedure for the concurrent estimation of urinary 4-hydroxy-3-methoxymandelic acid (HMMA) and homovanillic acid (HVA) using a scanning technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Further observations on the gas-chromatographic measurement of urinary phenolic and indolic metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A rapid and simple gas-liquid chromatographic procedure for homovanillic and vanillylmandelic acid in urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Gas chromatographic determination of urinary vanilglycolic acid, vanilglycol, vanilacetic acid and vanillactic acid — Chemical parameters for the diagnosis of neurogenic tumours and the evaluation of their treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of homovanillic, isohomovanillic and vanillylmandelic acids in human urine by means of glass capillary gas-liquid chromatography with temperature-programmed electron-capture detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of urinary homovanillic acid (HVA) using capillary gas chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary levels of vanilmandelic acid and homovanillic acid determined by high-speed liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Measurement of urinary vanilmandelic acid and homovanillic acid by high-performance liquid chromatography with electrochemical detection following extraction by ion-exchange and ion-moderated partition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simple high-performance liquid chromatographic method for the simultaneous measurement of vanillylmandelic acid and homovanillic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The determination of 3-methoxy 4-hydroxy mandelic acid in urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Quantitative colorimetric method for estimation of 3-methoxy-4-hydroxymandelic acid in urine; value in diagnosis of phaeochromocytoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The estimation of 4-hydroxy-3-methoxymandelic acid in urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A simple and rapid method for the determination of 4-hydroxy-3-methoxymandelic acid (HMMA) in urine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Gas chromatography in the estimation of urinary metanephrines and VMA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of urinary 3-methoxy-4-hydroxymandelic acid by gas-liquid chromatography as vanillyl alcohol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of 3-methoxy-4-hydroxyphenylglycol conjugates in urine. Application to the study of central noradrenaline metabolism in unmedicated chronic schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A method for determination of 3,4-dihydroxyphenylacetic acid and 3,4-dihydroxymandelic acid in urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Specific gas chromatographic measurement of urinary 3,4-dihydroxyphenylacetic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The determination of 5-methoxyindole-3-acetic acid in human urine by mass fragmentography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The determination of urinary phenylacetylglutamine as phenylacetic acid. Studies on its origin in normal subjects and children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary phenyl acetate: a diagnostic test for depression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Phenylethylamine excretion in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Identification and determination of 1-methylimidazole-4-acetic acid in human cerebrospinal fluid by gas chromatography-mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Phenylacetic acid in human cerebrospinal fluid and plasma: selected ion monitoring assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Phenylethylamine overproduction in aggressive psychopaths

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma concentrations of p- and m-hydroxyphenylacetic acid and phenylacetic acid in humans: gas chromatographic--high-resolution mass spectrometric analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma levels of phenylacetic acid, m- and p-hydroxyphenylacetic acid, and platelet monoamine oxidase activity in schizophrenic and other patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Trace acid levels in the plasma and MAO activity in the platelets of violent offenders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Platelet monoamine oxidase activity and trace acid levels in plasma of agoraphobic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Serum indole-3-acetic acid in control subjects and newly abstinent alcoholics after an oral loading with L-tryptophan: a preliminary study using liquid chromatography with amperometric detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Quantitative gas chromatographic mass spectrometric determination of mandelic acid in blood plasma. Comparison of deuterated and homologous internal standards

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous analysis of twelve biogenic amine metabolites in plasma, cerebrospinal fluid and urine by capillary column gas chromatography-high-resolution mass spectrometry with selected-ion monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Mass fragmentographic determination of vanilmandelic acid, homovanillic acid and isohomovanillic acid in human body fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Naloxone effects on ?-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Sex differences in plasma homovanillic acid in acute psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Mass fragmentographic determination of homovanillic and 4-hydroxy-3-methoxy mandelic acids in 50 microliter plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Elevated plasma homovanillic acid in depressed females with melancholia and psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of acidic catecholamine metabolites in plasma and cerebrospinal fluid using gas chromatography-negative-ion mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Acute psychosis and plasma catecholamine metabolites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Measurement of homovanillic acid in human plasma by high-performance liquid chromatography with electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Dexamethasone increases plasma HVA but not MHPG in normal humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous determination of free homovanillic acid, (3-methoxy-4-hydroxyphenyl)ethylene glycol, and vanilmandelic acid in human plasma by high-performance liquid chromatography coupled with dual-electrode coulometric electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A gas chromatographic-mass spectrometric (GC-MS) assay for 3-methoxy-4-hydroxyphenethyleneglycol and vanilmandelic acid in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effects of clorgyline and pargyline on deaminated metabolites of norepinephrine, dopamine and serotonin in human cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Measurement of plasma vanillylmandelic acid by liquid chromatography with electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Radioenzymatic assay for plasma dihydroxyphenylglycol (DHPG), dihydroxymandelic acid (DOMA) and dihydroxyphenylacetic acid (DOPAC)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma and cerebrospinal fluid concentration of phenylacetic acid in humans and monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of p-hydroxyphenylacetic acid in cerebrospinal fluid by high-performance liquid chromatography with electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The Origin of Indoleacetic Acid and Indolepropionic Acid in Rat and Human Cerebrospinal Fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A Method for the Simultaneous Determination of 5-Hydroxy-3-Indole-Acetic Acid (5-HIAA) and 5-Hydroxytryptamine (5-HT) in Brain Tissue and Cerebrospinal Fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Cerebrospinal fluid 5-hydroxyindoleacetic acid as an index of central serotonergic processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Amine metabolites, neuroendocrine findings, and personality dimensions as correlates of suicidal behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Biological correlations of suicide and aggressivity in major depressions (with melancholia): 5-hydroxyindoleacetic acid and cortisol in cerebral spinal fluid, dexamethasone suppression test and therapeutic response to 5-hydroxytryptophan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Comparison of benefit from L-dopa in Parkinsonism with increase of amine metabolites in the CSF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Treatment of Parkinson's disease with amantadine and levodopa. A one-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: A biochemical classification?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

5-Hydroxyindoles in Human Cerebrospinal Fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Concentrations of 5-Hydroxyindole-acetic Acid and Homovanillic Acid in the Cerebrospinal Fluid after Treatment with Probenecid in Patients with Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with senile dementia, presenile dementia and parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary 4-hydroxy-3-methoxyphenylglycol is not a predictor for clinical response to amitriptyline in depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Acid monoamine metabolites in cerebrospinal fluid from patients with presenile dementia (Alzheimer's disease).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Cerebral monoamines and depression. An investigation with the Probenecid technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Biogenic amines in 47, XYY syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Relationships between tryptophan in serum and CSF, and 5-hydroxyindoleacetic acid in CSF of man: effect of cirrhosis of liver and probenecid administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Measurement of acid monoamine metabolites in human and animal cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Phenolic acid concentrations in the lumbar cerebrospinal fluid of Parkinsonian patients treated with L-dopa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Homovanillic and 5-Hydroxyindoleacetic Acid in Cerebrospinal Fluid of Depressed Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Excretion of free and conjugated 5-HIAA and VMA in urine and concentration of 5-HIAA and HVA in CSF during migraine attacks and free intervals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF. Studies in patients with extrapyramidal disorders, epilepsy, and other diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Sites of origin in the central nervous system of monoamine metabolites measured in human cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effect of probenecid on free 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and its sulphate in human cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Correlation between cerebrospinal fluid amine metabolites and psychomotor activity in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Concentration gradients of monoamine metabolites in human cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Selected ion monitoring assay for biogenic amine metabolites and probenecid in human lumbar cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

CSF monoamine metabolites in depression and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Monoamine metabolites in CSF and suicidal behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Reduced lumbar CSF somatostatin in levels in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

CSF monoamine metabolites in mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

CSF monoamine metabolites in melancholia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid in adults with attention deficit disorder, residual type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determinations of 5-hydroxyindoleacetic acid and homovanillic acid in human CSF with monitoring of probenecid levels in CSF and plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

CSF monoamine metabolites in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous determination of the three major monoamine metabolites in cerebrospinal fluid by high-performance liquid chromatography with electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Isocratic analysis of 3-methoxy-4-hydroxyphenyl glycol, 5-hydroxyindole-3-acetic acid and 4-hydroxy-3-methoxyphenylacetic acid in cerebrospinal fluid by high-performance liquid chromatography with amperometric detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of neurotransmitter systems in human cerebrospinal fluid and rat nervous tissue by high-performance liquid chromatography with on-line data evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Serotonin and 5-hydroxyindoleacetic acid in CSF. Difference in Parkinson's disease and dementia of the Alzheimer's type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Different neurotransmitter metabolite concentrations in CSF samples from inpatient and outpatient normal volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

5-HIAA and HVA in CSF in patients with idiopathic pain disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Biochemical investigations in patients with Parkinson's disease treated with L-dopa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Concentrations of monoamine metabolites in human lumbar and cisternal cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Correlation of individual symptoms and other clinical variables with cerebrospinal fluid amine metabolites and tryptophan in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Central Monoamine Metabolism in Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Psychomotor Activity and Cerebrospinal Fluid Amine Metabolites in Affective Illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Mass fragmentographic determination of homovanillic acid in tissues and body fluids using the deuterium labeled species as internal standard

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The effect of probenecid on catecholamine metabolites in human cerebrospinal fluid analyzed by mass fragmentography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The simultaneous determination by selected ion monitoring of the levels of homovanillic, isohomovanillic, 3,4-dihydroxyphenylacetic and 3-methoxy-4-hydroxymandelic acids in single biological samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Conjugated 3,4 dihydroxy phenyl acetic acid (DOPAC) in human and monkey cerebrospinal fluid and rat brain and the effects of probenecid treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Central noradrenergic function in man: vanillylmandelic acid in CSF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous analysis of phenylglycols and phenylethanols in human urine by gas chromatography—mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Free and conjugated 3-methoxy-4-hydroxyphenylglycol in human urine: peripheral origin of glucuronide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

An improved procedure of 3-methoxy-4-hydroxyphenyl-ethylene glycol determination by gas-liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary excretion of 4-hydroxy-3-methoxyphenylglycol and 4-hydroxy-3-methoxyphenylethanol in man and rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A non-enzymic procedure for the quantitative analysis of (3-methoxy-4-sulphoxyphenyl)ethylene glycol (MHPG sulphate) in human urine using stable isotope dilution and gas chromatography—mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary 3-methoxy-4-hydroxyphenylglycol determination using reversed-phase chromatography with amperometric detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A radioenzymatic technique for the measurement of free and conjugated 3,4-dihydroxyphenylethylene-glycol in brain tissue and biological fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Control of exogenous factors affecting plasma homovanillic acid concentration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Dexamethasone suppression test and urinary MHPG X SO4 determination in depressive disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A fluorimetric method for the determination of 4-hydroxy-3-methoxyphenylglycol in urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Sulfate and glucuronide conjugates of 3-methoxy-4-hydroxyphenylglycol (MHPG) in urine of depressed patients: central and peripheral influences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of urinary 3-methoxy-4-hydroxyphenyl-ethylene glycol by gas-liquid chromatography and electron capture detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

3-Methoxy-4-hydroxy phenylglycol (MHPG) excretion in depressive states. A pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The determination of 4-hydroxy-3-methoxyphenylethylene glycol in urine and CSF using gas chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Depression and MHPG excretion. Response to dextroamphetamine and tricyclic antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Enzymatic hydrolysis of 3-methoxy-4-hydroxyphenethyl-eneglycol conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Primary affective disorder, clinical state change, and MHPG excretion: a longitudinal study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary 3-methoxy-4-hydroxyphenylglycol and psychiatric diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary MHPG in subgroups of depressed patients and normal controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Methodological issues in the measurement of urinary MHPG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Toward a biochemical classification of depressive disorders, V: Heterogeneity of unipolar depressions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary excretion of noradrenaline metabolite decreased in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Toward a biochemical classification of depressive disorders, VII: urinary free cortisol and urinary MHPG in depressions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. A replication and new findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Diurnal rhythm of 3-methoxy-4-hydroxyphenylglycol (MHPG): relationship between plasma and urinary levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Endogenous levels of free and conjugated urinary 3-methoxy-4-hydroxyphenylethyleneglycol in control subjects and patients with pheochromocytoma determined by reversed-phase liquid chromatography with electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of 3-methoxy-4-hydroxyphenylglycol in urine by high-performance liquid chromatography with amperometric detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

High-performance liquid chromatographic method for determining plasma and urine 3-methoxy-4-hydroxyphenylglycol by amperometric detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of plasma 3-methoxy-4-hydroxyphenylglycol by pulsed electron capture gas chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Presence of free, sulfate and glucuronide conjugated 3-methoxy-4-hydroxyphenylglycol (MHPG) in human brain, cerebrospinal fluid and plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Subtypes of Depression Based on Excretion of MHPG and Response to Nortriptyline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous determination of unconjugated homovanillic acid, vanilmandelic acid, and 3-methoxy-4-hydroxyphenylethylene glycol, in serum by mass fragmentography and deuterated internal standards

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous measurement of plasma 4-hydroxy-3-methoxyphenylethylene glycol and 3,4-dihydroxyphenylethylene glycol by gas chromatography mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma MHPG in Rapid Cyclers and Healthy Twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Covariance of plasma free 3-methoxy-4-hydroxyphenethyleneglycol and diastolic blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Adrenergic receptor sensitivity in depression. Effects of clonidine in depressed patients and healthy subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Impaired Presynaptic Regulation of Norepinephrine in Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Relative importance of 3-methoxy-4-hydroxyphenylglycol and 3,4-dihydroxyphenylglycol as norepinephrine metabolites in rat, monkey, and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The effects of caffeine on plasma MHPG, subjective anxiety, autonomic symptoms and blood pressure in healthy humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma MHPG levels in lactate and isoproterenol anxiety states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous determination of free 3-methoxy-4-hydroxymandelic acid and free 3-methoxy-4-hydroxyphenylethyleneglycol in plasma by liquid chromatography with electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of free 3-methoxy-4-hydroxyphenylglycol with several other monoamine metabolites in plasma by high-performance liquid chromatography with amperometric detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Assay of 3-methoxy-4-hydroxyphenylglycol in human plasma using high-performance liquid chromatography with amperometric detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Evaluation of plasma 3-methoxy-4-hydroxyphenylglycol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma MHPG in untreated panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Microassay of free 3-methoxy-4-hydroxyphenylglycol in plasma using high-performance liquid chromatography with electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Radioenzymatic assay of dihydroxyphenylglycol (DOPEG) and dihydroxyphenylethanol (DOPET) in plasma and cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Decrease in plasma levels of 3,4-dihydroxyphenylethyleneglycol in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Mass fragmentographic determination of 4-hydroxy-3-methoxyphenylglycol (HMPG) in urine, cerebrospinal fluid, plasma and tissues using a deuterium-labelled internal standard

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of total 3-methoxy-4-hydroxyphenylglycol in plasma using reversed-phase liquid chromatography with electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Afternoon continuous plasma levels of 3-methoxy-4-hydroxyphenylglycol and age. Distinctive biologic subgroups of endogenous depression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

3-Methoxy-4-Hydroxyphenylglycol in Cerebrospinal Fluid and Vanillylmandelic Acid in Urine of Humans with Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) in cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Central Norepinephrine Metabolism in Affective Illness: MHPG in the Cerebrospinal Fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Cerebrospinal fluid MHPG. An assessment of norepinephrine metabolism in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Quantitative determination of 3-methoxy-4-hydroxyphenylethyleneglycol and its sulfate conjugate in human lumbar cerebrospinal fluid using liquid chromatography with amperometric detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

3-methoxy-4-hydroxyphenylglycol in human cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

5-Hydroxytryptophol in human cerebrospinal fluid: Quantitative determination by gas chromatography-mass spectrometry using a obliterated internal standard

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Biogenic amine hypothesis of affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Dopamine and depression: A review of recent evidence. I. Empirical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Phenylethylamine in neuropsychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Phenylethylamine — a role in mental illness?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Abnormalities of indoleamines in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Precursors and metabolites of 5-hydroxytryptamine and dopamine in the ventricular cerebrospinal fluid of psychiatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary phenylacetic acid excretion in depressive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Cerebrospinal fluid 5-hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) following probenecid in unipolar depressives treated with amitriptyline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effects of amitriptyline and imipramine on amine metabolites in the cerebrospinal fluid of depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Cerebrospinal fluid adrenaline and noradrenaline in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Biochemical effects of L-deprenyl in atypical depressives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effect of Low-Dose Clorgyline on 24-Hour Urinary Monoamine Excretion in Patients With Rapidly Cycling Bipolar Affective Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Tryptamine metabolism in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Humoral changes in manic-depressive psychosis with particular reference to the excretion of catechol amines in urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Catecholamine metabolism of manic-depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The switch process from depression to mania: relationship to drugs which alter brain amines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The "switch process" in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Platelet and plasma amine oxidase inhibition and urinary amine excretion changes during phenelzine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Alterations in Motor Activity, Sleep, and Biochemistry in a Cycling Manic-Depressive Patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Changes in urinary catecholamines and their metabolites in depressed patients treated with amitriptyline or imipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Rapid antidepressant response to alprazolam in depressed patients with high catecholamine output and heterologous desensitization of platelet adenylate cyclase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

THE URINARY EXCRETION OF ADRENALINE, NORADRENALINE, AND 17-HYDROXYCORTICOSTEROIDS IN MENTAL ILLNESS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Biogenic amine and metabolite levels in depressed patients with high versus normal hypothalamic-pituitary-adrenocortical activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

L-Dopa, Dopamine, and Hypomania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Clinical and Biochemical Heterogeneity of Depressive Disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Increased excretion of dimethyltryptamine and certain features of psychosis: a possible association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin output

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effects of Antidepressant Treatments on Dopamine Turnover in Depressed Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Blood noradrenaline and 5-HT levels in depressed women during amitriptyline or lithium treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous study of 24-hour patterns of melatonin and cortisol secretion in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Reliability of Norepinephrine and Major Monoamine Metabolite Measurements in CSF of Schizophrenic Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Gas-liquid chromatographic determination of total phenylacetic acid in urine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

EXCRETION OF 3-METHOXY-4-HYDROXYMANDELIC ACID (VMA) IN DEPRESSED PATIENTS TREATED WITH ANTIDEPRESSANT DRUGS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Indole-3-acetic acid in human cerebrospinal fluid: identification and quantification by mass fragmentography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Initial clinical trial based on biochemical methodology of zimelidine (a serotonin uptake inhibitor) in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Studies on sodium transfer and 5-hydroxyindoles in depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Influence of convulsive therapy on 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid in endogenous depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

REM sleep and central monoamine oxidase inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Biogenic Amine Metabolites in Cerebrospinal Fluid of Depressed and Manic Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Changes on recovery in the concentrations of tryptophan and the biogenic amine metabolites in the cerebrospinal fluid of patients with affective illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The effect of lithium treatment on manic symptoms and levels of monoamine metabolites in cerebrospinal fluid of manic depressive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effect of ECT and imipramine treatment on the concentration of 5-hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) in the cerebrospinal fluid of depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: I. General patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Serotonin and Dopamine Disturbances in Patients with Unipolar Depressin and Parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Antidepressant effect of femoxetine and desipramine and relationship to the concentration of amine metabolites in cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effects of ECT on sleep and CSF biogenic amines in affective illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Ventricular size and CSF transmitter metabolite concentrations in severe endogenous depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Monoamine neurotransmitter interactions and the prediction of antidepressant response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Bupropion in depression. I. Biochemical effects and clinical response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Mass fragmentometric determination of homovanillic acid in lumbar cerebrospinal fluid of schizophrenic patients during treatment with antipsychotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Daily variations of the urine content of 3-methoxy-4-hydroxyphenylglycol in two manic-depressive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

MHPG excretion in depressive disorders: relation to clinical subtypes and desynchronized sleep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Delusional versus non-delusional depression: Neurochemical differences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Response to Amitriptyline and Urinary MHPG in Bipolar Depressive Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary MHPG and clinical response to amitriptyline in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary MHPG and ward behavior in unmedicated psychiatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Elevations of urinary MHPG in depressed patients with panic attacks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary MHPG, platelet 3H-imipramine binding and symptomatology in depression: an exploratory study of clinical heterogeneity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Alpha-2 adrenergic receptor sensitivity and the mechanism of action of antidepressant therapy. The effect of long-term amitriptyline treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Noradrenergic function and the cortisol response to dexamethasone in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Elevated 3,4-dihydroxyphenylethyleneglycol (DHPG) excretion in dexamethasone resistant depressed patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma catecholamine metabolites in subtypes of major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Lack of correlation between plasma DOPEG and urinary MOPEG levels in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Quantitative determination of 4-hydroxy-3-methoxyphenyl glycol and its conjugates in cerebrospinal fluid by mass fragmentography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

New evidence of serotonin-deficient depressions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

CSF-MHPG in Depressive Syndromes: Basal Values and Imipramine-Induced Modifications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Decreased Urinary Output of Tyramine and its Metabolites in Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Decreased conjugated tyramine outputs in depression: gastrointestinal factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Decreased urinary output of conjugated tyramine is associated with lifetime vulnerability to depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Tyramine-conjugation deficit as a trait-marker in endogenous depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The tyramine challenge test as a marker for melancholia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Cerebrospinal Fluid Amine Metabolites in Acute Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Catecholamine Excretion in Manic-Depressive and Schizophrenic Psychosis and its Relationship to Symptomatology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Cerebrospinal fluid norepinephrine in affective illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary Catecholamine Metabolites during Behavioral Changes in a Patient with Manic-Depressive Cycles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Vanilmandelicaciduria in the Different Clinical Phases of Manic Depressive Psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Catecholamines and affective disorders revised: a critical assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Biochemical changes in psychotic depression. High norepinephrine levels in psychotic vs neurotic depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

State anxiety, physical activity, and urinary 3-methoxy-4-hydroxyphenethylene glycol excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Homicide, suicide and CSF 5-HIAA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

CSF-amine metabolites in depression, dementia and in controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

CSF 5HIAA and personal and family history of suicide in affectively III patients: A negative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Rorschach ratings in depressed and suicidal patients with low levels of 5-hydroxyindoleacetic acid in cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary MHPG levels and tricyclic antidepressant drug selection. A preliminary communication on improved drug selection in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

CSF amine metabolites and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Panic attacks and alcohol withdrawal: can subjects differentiate the symptoms?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Lack of correlation between DST results and urinary MHPG in depressed inpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Consistent evidence for a biological subtype of depression characterized by low CSF monoamine levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Neurochemical variables in delusional depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: II. Suicide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Biological component of the NIMH Clinical Research Branch Collaborative Program on the psychobiology of depression: I. Background and theoretical considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Multiple biochemical correlates of manic-depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Pretreatment urinary MHPG levels as predictors of antidepressant responses to alprazolam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: interactions with yohimbine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The effects of antidepressants on the cerebrospinal fluid homovanillic acid/5-hydroxyindoleacetic acid ratio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Normetanephrine Excretion and Affective State in Depressed Patients Treated with Imipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A clinical and biochemical study of a trial of iproniazid in the treatment of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Rapid analysis of beta-phenylethylamine in tissues and body fluids utilizing pentafluorobenzoylation followed by electron-capture gas chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Reduction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Increased Plasma MHPG in Dexamethasone-Resistant Depressed Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

High levels of plasma catecholamines in dexamethasone-resistant depressed patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Schizophrenia: Some Current Neurochemical Approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary dimethyltryptamine and psychiatric symptomatology and classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Hallucinogenic N-Methylated Indolealkylamines in the Cerebrospinal Fluid of Psychiatric and Control Populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

URINARY TRYPTAMINE AND INDOLE-3-ACETIC ACID EXCRETION BY SCHIZOPHRENIC PATIENTS: USE OF THE TRYPTAMINE/INDOLE ACETIC ACID RATIO AS AN INDEX OF MONOAMINE OXIDASE INHIBITION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Excretion patterns of tryptamine, indoleacetic acid, and 5-hydroxyindoleacetic acid, and their correlation with mental changes in schizophrenic patients under medication with alpha-methyldopa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

EXCRETION OF CATECHOLAMINES AND EXACERBATION OF SYMPTOMS IN SCHIZOPHRENIC PATIENTS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Catecholamine Metabolism in Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Identification of 3,4-Dimethoxyphenethylamine from Schizophrenic Urine by Mass Spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Long-term neuroleptic treatment of chronic schizophrenic patients: Clinical and biochemical effects of withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma noradrenaline and clinical psychopathology in schizophrenia. A correlation analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high performance liquid chromatography and gas chromatography-mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Phenylethylamine and monoamine metabolites in CSF of schizophrenics: Effects of neuroleptic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schizophrenic patients after withdrawal of long-term neuroleptic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

URINARY METABOLITES OF SOME MONOAMINES AND CLINICAL EFFECTS UNDER RESERPINE AND CHLORPROMAZINE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The effect of haloperidol on the urinary excretion of dopamine, homovanillic and vanilmandelic acids in schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Occurrence of 3,4-Dimethoxyphenylacetic Acid in Urines of Normal and Schizophrenic Individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Menstrual cycle affects plasma HVA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effect of probenecid on the concentration of the lumbar cerebrospinal fluid acidic metabolites of tyramine, octopamine, dopamine and norepinephrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Clinical and Pharmacological Effects of Monoamine Precursors or Haloperidol in Chronic Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous quantification of homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid by mass fragmentography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effects of melperone and thiothixene on prolactin levels in cerebrospinal fluid and plasma of psychotic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A Liquid Chromatographic Assay for 5-Hydroxytryptophan, Serotonin and 5-Hydroxyindoleacetic Acid in Human Body Fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Mass fragmentographic analysis of homovanillic acid and its homoiso analogue in cerebrospinal fluid using the ?-dideutero acid as internal standard

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The effect of chlorpromazine on homovanillic acid levels in cerebrospinal fluid of schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

3,4-Dihydroxyphenylacetic acid and homovanillic acid in serum and cerebrospinal fluid of psychotic patients estimated by a gas chromatographic method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Early neuroleptic response in psychotic men and women: correlation with plasma HVA and MHPG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Short-term haloperidol administration acutely elevates human plasma homovanillic acid concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma homovanillic acid as a predictor of response to neuroleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

3-Methoxy-4-hydroxyphenylglycol excretion in acutely schizophrenic patients during a controlled clinical trial of the isomers of flupenthixol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Correlation of behavior and catecholamine metabolite excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A fluorometric method combined with thin layer chromatography for the determination of norepinephrine, epinephrine and dopamine in human urine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Structural brain pathology in schizophrenia revisited. Prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

5-Hydroxyindoleacetic acid (5 HIAA) and homovanillic acid (HVA) following probenecid in acute psychotic patients treated with phenothiazines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma homovanillic acid and tardive dyskinesia during neuroleptic maintenance and withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Further studies with propranolol in psychotic patients. Relation to initial psychiatric state, urinary catecholamines and 3-methoxy-4-hydroxyphenylglycol excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Clinical and biochemical effects of verapamil administration to schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Low-dose apomorphine reduces serum homovanillic acid concentrations in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Are paranoid schizophrenics biologically different from other schizophrenics?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid after treatment with probenecid in patients with drug-induced tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary Excretion of 3,4-Dimethoxyphenylethylamine in Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The effect of L-Dopa on monoamine metabolites in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Concentration of homovanillic acid in the ventricular fluid of patients with Parkinson's disease and other dyskinesias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Dopamine and basal ganglia disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Cerebrospinal fluid levels of 3-methoxy4hydroxyphenylethylene glycol in Parkinsonism before and after treatment with L-DOPA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effect of L-Dopa Therapy on Urinary p-Tyramine Excretion and EEG Changes in Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Predictive Value of the Probenecid Test for the Effect of L-Dopa Therapy in Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Serial determinations of homovanillinic acid in the cerebrospinal fluid of Parkinson patients treated with L-dopa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

L-dopa and cerebrospinal fluid homovanillic acid in parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Failure of cerebrospinal fluid homovanillic acid to predict levodopa response in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Serotonergic mechanisms in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The metabolism of orally administered l-DOPA in Parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

CSF neurotransmitter markers in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Transmitter deficits in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Cerebrospinal fluid monoamine metabolite levels in male arsonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The effect of methylphenidate on urinary catecholamine excretion in hyperactivity: a partial replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Norepinephrine metabolism and clinical response to dextroamphetamine in hyperactive boys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effects of d-amphetamine on urinary metabolites of dopamine and norepinephrine in hyperactive boys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Central monoamines and hyperkinase of childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary catecholamines and amphetamine excretion in hyperactive and normal boys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary catecholamine metabolites in hyperkinetic boys treated with d-amphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary excretion of catecholamine metabolites in hyperkinetic child syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary MHPG excretion in minimal brain dysfunction and its modification by d-amphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Excretion of 5-hydroxyindolyl acetic acid (5HIAA) in migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Interrelations between age and plasma renin, aldosterone and cortisol, urinary catecholamines, and the body sodium/volume state in normal man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Variability of plasma catecholamine levels: age, duration of posture and time of day

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Biochemical aspects of indole metabolism in normal and schizophrenic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Alcohol and Central Serotonin Metabolism in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Relationship of Monoamine Metabolites in Human Cerebrospinal Fluid to Age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The current status of the dopamine hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The adrenergic amines of human blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous determination of the major acidic metabolites of catecholamines and serotonin in urine by liquid chromatography with electrochemical detection after a one-step sample clean-up on Sephadex G-10; influence of vanilla and banana ingestion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Direct determination of 3-methoxy-4-sulphonyloxyphenylglycol (MHPG sulphate) in urine using gas-liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Method for total 3-methoxy-4-hydroxyphenylglycol extraction from urine, plasma and brain tissue using bonded-phase materials: comparison with the ethyl acetate extraction method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Specific quantitation of urinary 6-hydroxymelatonin sulphate by gas chromatography mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Quantitative analysis of 6-hydroxymelatonin in human urine by gas chromatography--negative chemical ionization mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A new derivative for the gas-liquid chromatographic determination of homovanillic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of beta-phenylethylamine concentrations in human plasma, platelets, and urine and in animal tissues by high-performance liquid chromatography with fluorometric detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Studies on histamine in human urine using a fluorometric method of assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Quantitation of histamine and some of its basic methylated metabolites in biological materials by gas-liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The role of serotonin in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

5-Hydroxyindoleacetic acid in cerebrospinal fluid--methodological and clinical aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Amine Metabolites in Human Cerebrospinal Fluid: Effects of Cord Transection and Spinal Fluid Block

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Gradients of monoamine metabolites and cortisol in cerebrospinal fluid of psychiatric patients and healthy controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Histamine metabolism during the menstrual cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Norepinephrine and 3-methoxy-4-hydroxyphenyl glycol gradients in human cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Site of Lumbar Puncture Influences Levels of Monoamine Metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma 3-Methoxy-4-Hydroxyphenylglycol Changes Associated With Clinical State and Schizophrenic Subtype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Preliminary evidence of reduced combined output of dopamine and its metabolites in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Panic-induced elevation of plasma MHPG levels in phobic-anxious patients. Effects of clonidine and imipramine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A Possible Genetic Factor Related to Psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Serotonin metabolite concentrations in cerebrospinal fluid from schizophrenic patients -- relationships to family history

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Relationships in Healthy Volunteers Between Concentrations of Monoamine Metabolites in Cerebrospinal Fluid and Family History of Psychiatric Morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The urinary excretion of 2-phenylethylamine in phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Routine reversed-phase high-performance liquid chromatographic measurement of urinary vanillylmandelic acid in patients with neural crest tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The diagnosis of pheochromocytoma by determination of urinary 3-methoxy-4-hydroxymandelic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A simple and specific radioenzymatic assay for measurement of urinary normetanephrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma normetanephrine measurements for detection of pheochromocytoma in patients with hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

High-performance liquid chromatography of 5-hydroxyindole-3-acetic acid in urine with direct sample injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effects of large variations in diet on free catecholamines and their metabolites in urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

4-Hydroxy-3-methoxymandelic acid (HMMA) in the urine of normal and fasting subjects and in patients with colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

A method for the gas chromatographic determination of urinary 1,4-methyl-imidazoleacetic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The effects of diet and physical activity on plasma homovanillic acid in normal human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Excretion of beta-phenethylamine is elevated in humans after profound stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Serotonin content of foods: effect on urinary excretion of 5-hydroxyindoleacetic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effect of eating bananas on plasma free and sulfate-conjugated catecholamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Interaction of biogenic amines with components of cigarette smoke. Formation of cyanomethylamine derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

ETHANOL AND URINARY CATECHOLAMINES IN MAN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Adrenal function and alcoholism. II. Catecholamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Acute effects of moderate alcohol consumption on blood pressure and plasma catecholamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Alteration of Endogenous Catecholamine Metabolism by Ethanol Ingestion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Central Norepinephrine Metabolism During Alcohol Intoxication in Addicts and Healthy Volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Relationships between catecholamine or 3-methoxy 4-hydroxy phenylglycol changes and the mental performance under submaximal exercise in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Epinephrine and norepinephrine responses in continuously collected human plasma to a series of stressors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effect of cold pressor stimulation on plasma norepinephrine, dopamine-beta-hydroxylase, and renin activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The Relationship between Plasma Catecholamine Concentration and Pulse Rate during Exercise and Standing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Arterial noradrenaline concentration during exercise in relation to the relative work levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effect of physical activity on urinary M.H.P.G. excretion in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Relation of Exercise to MHPG Excretion in Normal Subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Plasma and sweat histamine concentrations after heat exposure and physical exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

THE URINARY OUTPUT OF ADRENALIN AND NORADRENALIN DURING PLEASANT AND UNPLEASANT EMOTIONAL STATES. A PRELIMINARY REPORT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The stress of aircraft carrier landings. II. 3-methoxy-4-hydroxyphenylglycol excretion in naval aviators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Comparison of urinary and plasma catecholamine responses to mental stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Renin, norepinephrine, and epinephrine responses to graded exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Adrenergic responses of asthmatic and normal subjects to submaximal and maximal work levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Rapid and simple procedure for the determination of urinary phenylacetic acid using derivatization in aqueous medium followed by electron-capture gas chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The correlation between human plasma melatonin levels and urinary 6-hydroxymelatonin excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Melatonin radioimmunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary hormone levels: a population study of associations between steroid and catecholamine excretion rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of catecholamines in urine by ion-exchange liquid chromatography with electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The estimation of catechol amines in urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Diurnal variation of plasma catecholamines and systolic time intervals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Circadian variations of plasma catecholamine, cortisol and immunoreactive insulin concentrations in supine subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Ultradian variations of plasma noradrenaline in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

The diurnal variation in plasma homovanillic acid level persists but the variation in 3-methoxy-4-hydroxyphenylglycol level is abolished under constant conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary 3-methoxy-4-hydroxyphenylglycol circadian rhythm. Early timing (phase-advance) in manic-depressives compared with normal subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Lack of circadian rhythm in plasma levels of 3,4-dihydroxyphenylethyleneglycol in healthy human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Circadian variation in 5-hydroxyindoleacetic acid levels in human cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Seasonality in biochemical determinations: A source of variance and a clue to the temporal incidence of affective illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Seasonal variations of human lumbar CSF neurotransmitter metabolite concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Seasonal variations in the stability of monoamines and their metabolites in perchloric acid as measured by high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Validity of plasma-catecholamine estimations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Stability of human plasma catecholamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Determination of serotonin and 5-hydroxyindoleacetic acid in urine by reversed-phase ion-pair partition chromatography with fluorimetric detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Degradation study of catecholamines, indole amines and some of their metabolites in different extraction media by chromatography and electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Effects of long-term storage on the concentrations of the unconjugated acidic metabolites of the trace amines, indoleamines and catecholamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Urinary excretion of free bufotenin by psychiatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

Negative-Ion Mass Spectrometry Fused-Silica Capillary Gas Chromatography of Neurotransmitters and Related Compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

7 January 2021

HISTAMINE IN HUMAN URINE.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

1 reference

7 January 2021

Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

7 January 2021

Amine metabolites in the lumbar cerebrospinal fluid of humans with restricted flow of cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

7 January 2021

Studies of CSF 5-HIAA in depression and suicidal behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

7 January 2021

Rapid elevation of biogenic amine metabolites in human CSF following probenecid

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

7 January 2021

Specific norepinephrine and serotonin uptake inhibitors in man: a crossover study with pharmacokinetic, biochemical, neuroendocrine and behavioral parameters.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

1 reference

7 January 2021

Catecholamines in Plasma and Urine in Patients with Essential Hypertension Determined by Double‐Isotope Derivative Techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

7 January 2021

QUANTITATION OF STRESS BY CATECHOLAMINE ANALYSIS.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2984617-3

7 January 2021

10.1016/S0021-9673(01)84617-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2663901%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

1 reference